Skip to main content
Erschienen in: European Journal of Epidemiology 2/2016

28.12.2015 | RESPIRATORY DISEASE

Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease

verfasst von: Martin Söderholm, Malin Inghammar, Bo Hedblad, Arne Egesten, Gunnar Engström

Erschienen in: European Journal of Epidemiology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

It is uncertain whether the incidence of stroke is increased in patients with chronic obstructive pulmonary disease (COPD), and whether COPD is associated with all subtypes of stroke (i.e. ischemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage). We evaluated the association between COPD and incidence of stroke in a nation-wide cohort study. All individuals between 40 and 84 years of age, hospitalised for COPD between 1987 and 2003 in Sweden were identified in the Swedish hospital discharge register. For each COPD patient (n = 103,419), one reference individual was randomly selected from the general population matched for year of birth, sex and county of residence. After excluding subjects with prior stroke, incidence rates during 10 years follow-up were calculated. Hazard ratios (HR) for stroke comparing COPD patients with reference subjects were estimated using Cox regression adjusting for demographics and comorbidities. Incidence of all-cause stroke (n events = 17,402) was significantly increased in COPD patients compared to reference individuals (HR 1.24, 95 % CI 1.19–1.28), especially during the first 2 years after COPD diagnosis (HR 1.46, 1.37–1.55). Incidences of ischemic stroke (HR 1.20, 1.15–1.25), intracerebral haemorrhage (HR 1.29, 1.16–1.43) and subarachnoid haemorrhage (HR 1.46, 1.16–1.85) were all increased in COPD patients. Incidences of all stroke subtypes are increased in COPD, especially during the first years after COPD diagnosis. The association was independent of several comorbidities, although residual confounding from smoking and hypertension cannot be excluded. A global evaluation of stroke risk factors seems warranted in patients with COPD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–50.CrossRefPubMed Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–50.CrossRefPubMed
2.
Zurück zum Zitat Lundbäck B, Lindberg A, Lindström M, et al. Not 15 but 50 % of smokers develop COPD?—Report from the obstructive lung disease in Northern Sweden Studies. Respir Med. 2003;97(2):115–22.CrossRefPubMed Lundbäck B, Lindberg A, Lindström M, et al. Not 15 but 50 % of smokers develop COPD?—Report from the obstructive lung disease in Northern Sweden Studies. Respir Med. 2003;97(2):115–22.CrossRefPubMed
3.
Zurück zum Zitat Gershon AS, Warner L, Cascagnette P, Victor JC, To T. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet. 2011;378(9795):991–6.CrossRefPubMed Gershon AS, Warner L, Cascagnette P, Victor JC, To T. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet. 2011;378(9795):991–6.CrossRefPubMed
4.
Zurück zum Zitat Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet. 1997;349(9064):1498–504.CrossRefPubMed Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet. 1997;349(9064):1498–504.CrossRefPubMed
5.
Zurück zum Zitat Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355–69.CrossRefPubMed Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355–69.CrossRefPubMed
6.
Zurück zum Zitat O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112–23.CrossRefPubMed O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112–23.CrossRefPubMed
7.
Zurück zum Zitat Feigin VL, Rinkel GJ, Lawes CM, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke. 2005;36(12):2773–80.CrossRefPubMed Feigin VL, Rinkel GJ, Lawes CM, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke. 2005;36(12):2773–80.CrossRefPubMed
8.
Zurück zum Zitat Ariesen MJ, Claus SP, Rinkel GJ, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke. 2003;34(8):2060–5.CrossRefPubMed Ariesen MJ, Claus SP, Rinkel GJ, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke. 2003;34(8):2060–5.CrossRefPubMed
9.
Zurück zum Zitat Söderholm M, Zia E, Hedblad B, Engström G. Lung function as a risk factor for subarachnoid hemorrhage: a prospective cohort study. Stroke. 2012;43(10):2598–603.CrossRefPubMed Söderholm M, Zia E, Hedblad B, Engström G. Lung function as a risk factor for subarachnoid hemorrhage: a prospective cohort study. Stroke. 2012;43(10):2598–603.CrossRefPubMed
10.
Zurück zum Zitat Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128(4):2068–75.CrossRefPubMed Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128(4):2068–75.CrossRefPubMed
11.
Zurück zum Zitat Lindberg A, Larsson LG, Rönmark E, Lundbäck B. Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function. COPD. 2011;8(6):421–8.CrossRefPubMed Lindberg A, Larsson LG, Rönmark E, Lundbäck B. Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function. COPD. 2011;8(6):421–8.CrossRefPubMed
12.
Zurück zum Zitat Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–9.CrossRefPubMed Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–9.CrossRefPubMed
13.
Zurück zum Zitat Johnston AK, Mannino DM, Hagan GW, Davis KJ, Kiri VA. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax. 2008;63(7):599–605.CrossRefPubMed Johnston AK, Mannino DM, Hagan GW, Davis KJ, Kiri VA. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax. 2008;63(7):599–605.CrossRefPubMed
14.
Zurück zum Zitat Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ. 1996;313(7059):711–5 (discussion 5–6).CrossRefPubMedPubMedCentral Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ. 1996;313(7059):711–5 (discussion 5–6).CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Hozawa A, Billings JL, Shahar E, Ohira T, Rosamond WD, Folsom AR. Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities study. Chest. 2006;130(6):1642–9.CrossRefPubMed Hozawa A, Billings JL, Shahar E, Ohira T, Rosamond WD, Folsom AR. Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities study. Chest. 2006;130(6):1642–9.CrossRefPubMed
16.
Zurück zum Zitat Schneider C, Bothner U, Jick SS, Meier CR. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010;25(4):253–60.CrossRefPubMed Schneider C, Bothner U, Jick SS, Meier CR. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010;25(4):253–60.CrossRefPubMed
17.
Zurück zum Zitat Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005;128(4):2640–6.CrossRefPubMed Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005;128(4):2640–6.CrossRefPubMed
18.
Zurück zum Zitat Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006;16(1):63–70.CrossRefPubMed Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006;16(1):63–70.CrossRefPubMed
19.
Zurück zum Zitat Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010;65(11):956–62.CrossRefPubMed Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010;65(11):956–62.CrossRefPubMed
20.
Zurück zum Zitat Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.CrossRefPubMedPubMedCentral Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Inghammar M, Engström G, Löfdahl CG, Egesten A. Validation of a COPD diagnosis from the Swedish Inpatient Registry. Scand J Public Health. 2012;40(8):773–6.CrossRefPubMed Inghammar M, Engström G, Löfdahl CG, Egesten A. Validation of a COPD diagnosis from the Swedish Inpatient Registry. Scand J Public Health. 2012;40(8):773–6.CrossRefPubMed
22.
Zurück zum Zitat Agnarsson U, Thorgeirsson G, Sigvaldason H, Sigfusson N. Effects of leisure-time physical activity and ventilatory function on risk for stroke in men: the Reykjavik Study. Ann Intern Med. 1999;130(12):987–90.CrossRefPubMed Agnarsson U, Thorgeirsson G, Sigvaldason H, Sigfusson N. Effects of leisure-time physical activity and ventilatory function on risk for stroke in men: the Reykjavik Study. Ann Intern Med. 1999;130(12):987–90.CrossRefPubMed
23.
Zurück zum Zitat Truelsen T, Prescott E, Lange P, Schnohr P, Boysen G. Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. Int J Epidemiol. 2001;30(1):145–51.CrossRefPubMed Truelsen T, Prescott E, Lange P, Schnohr P, Boysen G. Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. Int J Epidemiol. 2001;30(1):145–51.CrossRefPubMed
24.
Zurück zum Zitat Zia E, Melander O, Björkbacka H, Hedblad B, Engström G. Total and differential leucocyte counts in relation to incidence of stroke subtypes and mortality: a prospective cohort study. J Intern Med. 2012;272(3):298–304.CrossRefPubMed Zia E, Melander O, Björkbacka H, Hedblad B, Engström G. Total and differential leucocyte counts in relation to incidence of stroke subtypes and mortality: a prospective cohort study. J Intern Med. 2012;272(3):298–304.CrossRefPubMed
25.
Zurück zum Zitat Johnson LS, Juhlin T, Engström G, Nilsson PM. Reduced forced expiratory volume is associated with increased incidence of atrial fibrillation: the Malmö Preventive Project. Europace. 2013;16(2):182–8. Johnson LS, Juhlin T, Engström G, Nilsson PM. Reduced forced expiratory volume is associated with increased incidence of atrial fibrillation: the Malmö Preventive Project. Europace. 2013;16(2):182–8.
26.
Zurück zum Zitat Engström G, Wollmer P, Hedblad B, Juul-Möller S, Valind S, Janzon L. Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a study from “Men born in 1914,” Malmö, Sweden. Circulation. 2001;103(25):3086–91.CrossRefPubMed Engström G, Wollmer P, Hedblad B, Juul-Möller S, Valind S, Janzon L. Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a study from “Men born in 1914,” Malmö, Sweden. Circulation. 2001;103(25):3086–91.CrossRefPubMed
27.
Zurück zum Zitat Ford ES, Wheaton AG, Mannino DM, Presley-Cantrell L, Li C, Croft JB. Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007–2010. Respir Res. 2012;13:115.CrossRefPubMedPubMedCentral Ford ES, Wheaton AG, Mannino DM, Presley-Cantrell L, Li C, Croft JB. Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007–2010. Respir Res. 2012;13:115.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Garcia Rodriguez LA, Wallander MA, Tolosa LB, Johansson S. Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors. COPD. 2009;6(5):369–79.CrossRefPubMed Garcia Rodriguez LA, Wallander MA, Tolosa LB, Johansson S. Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors. COPD. 2009;6(5):369–79.CrossRefPubMed
29.
Zurück zum Zitat Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010;137(5):1091–7.CrossRefPubMed Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010;137(5):1091–7.CrossRefPubMed
30.
Zurück zum Zitat Halpin DM, Decramer M, Celli B, Kesten S, Leimer I, Tashkin DP. Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT(R) trial. Lung. 2011;189(4):261–8.CrossRefPubMedPubMedCentral Halpin DM, Decramer M, Celli B, Kesten S, Leimer I, Tashkin DP. Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT(R) trial. Lung. 2011;189(4):261–8.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Stegmayr B, Asplund K. Measuring stroke in the population: quality of routine statistics in comparison with a population-based stroke registry. Neuroepidemiology. 1992;11(4–6):204–13.CrossRefPubMed Stegmayr B, Asplund K. Measuring stroke in the population: quality of routine statistics in comparison with a population-based stroke registry. Neuroepidemiology. 1992;11(4–6):204–13.CrossRefPubMed
32.
Zurück zum Zitat Merlo J, Lindblad U, Pessah-Rasmussen H, et al. Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers. Eur J Epidemiol. 2000;16(3):235–43.CrossRefPubMed Merlo J, Lindblad U, Pessah-Rasmussen H, et al. Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers. Eur J Epidemiol. 2000;16(3):235–43.CrossRefPubMed
33.
Zurück zum Zitat Appelros P, Terent A. Validation of the Swedish inpatient and cause-of-death registers in the context of stroke. Acta Neurol Scand. 2011;123(4):289–93.CrossRefPubMed Appelros P, Terent A. Validation of the Swedish inpatient and cause-of-death registers in the context of stroke. Acta Neurol Scand. 2011;123(4):289–93.CrossRefPubMed
34.
Zurück zum Zitat Köster M, Asplund K, Johansson A, Stegmayr B. Refinement of Swedish administrative registers to monitor stroke events on the national level. Neuroepidemiology. 2013;40(4):240–6.CrossRefPubMed Köster M, Asplund K, Johansson A, Stegmayr B. Refinement of Swedish administrative registers to monitor stroke events on the national level. Neuroepidemiology. 2013;40(4):240–6.CrossRefPubMed
35.
Zurück zum Zitat Montnemery P, Adelroth E, Heuman K, et al. Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden. Respir Med. 1998;92(12):1337–45.CrossRefPubMed Montnemery P, Adelroth E, Heuman K, et al. Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden. Respir Med. 1998;92(12):1337–45.CrossRefPubMed
36.
Zurück zum Zitat Montnemery R, Nihlen U, Andersson M, et al. Obstructive airways diseases, smoking and use of inhaled corticosteroids in southern Sweden in 1992 and 2000. Int J Tuberc Lung Dis. 2006;10(5):490–8.PubMed Montnemery R, Nihlen U, Andersson M, et al. Obstructive airways diseases, smoking and use of inhaled corticosteroids in southern Sweden in 1992 and 2000. Int J Tuberc Lung Dis. 2006;10(5):490–8.PubMed
37.
Zurück zum Zitat Danielsson M, Gilliam H, Hemström Ö. Tobaksvanor och tobaksrelaterade sjukdomar. Public health report 2009. National board of Health and Welfare, Sweden. 2009; pp. 291–310. Danielsson M, Gilliam H, Hemström Ö. Tobaksvanor och tobaksrelaterade sjukdomar. Public health report 2009. National board of Health and Welfare, Sweden. 2009; pp. 291–310.
38.
Zurück zum Zitat Lindberg A, Bjerg A, Rönmark E, Larsson LG, Lundbäck B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2006;100(2):264–72.CrossRefPubMed Lindberg A, Bjerg A, Rönmark E, Larsson LG, Lundbäck B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2006;100(2):264–72.CrossRefPubMed
39.
Zurück zum Zitat Lindberg A, Larsson LG, Muellerova H, Rönmark E, Lundbäck B. Up-to-date on mortality in COPD—report from the OLIN COPD study. BMC Pulm Med. 2012;12:1.CrossRefPubMedPubMedCentral Lindberg A, Larsson LG, Muellerova H, Rönmark E, Lundbäck B. Up-to-date on mortality in COPD—report from the OLIN COPD study. BMC Pulm Med. 2012;12:1.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Löfdahl CG, Tilling B, Ekström T, Jörgensen L, Johansson G, Larsson K. COPD health care in Sweden—a study in primary and secondary care. Respir Med. 2010;104(3):404–11.CrossRefPubMed Löfdahl CG, Tilling B, Ekström T, Jörgensen L, Johansson G, Larsson K. COPD health care in Sweden—a study in primary and secondary care. Respir Med. 2010;104(3):404–11.CrossRefPubMed
Metadaten
Titel
Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease
verfasst von
Martin Söderholm
Malin Inghammar
Bo Hedblad
Arne Egesten
Gunnar Engström
Publikationsdatum
28.12.2015
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 2/2016
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-015-0113-7

Weitere Artikel der Ausgabe 2/2016

European Journal of Epidemiology 2/2016 Zur Ausgabe